Clincosm LogoSign in Get a demo

Does Clomiphene Citrate Used for Induction of Ovulation Effect Levels of AMH and Inhibin B

Sponsor
Bagcilar Training and Research Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT02036411
Collaborator
(none)
40
Enrollment
1
Location
4
Duration (Months)
10
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

100mg clomiphene citrate used for ovulation induction. The investigators take blood sample at 3 and 10 days of menstruation and count AMH and inhibin B.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    100mg clomiphene citrate used for ovulation induction. The investigators take blood sample at 3 and 10 days of menstruation. AMH and inhibit B level will be measured in serum. We want to search relation of AMH, inhibin b and ovulation induction.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    40 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Does Clomiphene Citrate Used for Induction of Ovulation Effect Levels of AMH and Inhibin B
    Study Start Date :
    Sep 1, 2013
    Anticipated Primary Completion Date :
    Jan 1, 2014
    Anticipated Study Completion Date :
    Jan 1, 2014

    Outcome Measures

    Primary Outcome Measures

    1. Does Clomiphene Citrate Used for Induction of Ovulation Effect Levels of AMH level [1 week]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 35 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Infertility treatment
    Exclusion Criteria:

    • Previous ovarian surgery

    • Single functioning ovary

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Bagcilar Training and Research Hospital İstanbul Turkey 34200

    Sponsors and Collaborators

    • Bagcilar Training and Research Hospital

    Investigators

    • Principal Investigator: TANER USTA, M.D, Bagcilar Training and Research Hospital, Istanbul, Turkey.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Taner A Usta, MD, MD, Bagcilar Training and Research Hospital
    ClinicalTrials.gov Identifier:
    NCT02036411
    Other Study ID Numbers:
    • BEH GynObs-5
    First Posted:
    Jan 15, 2014
    Last Update Posted:
    Jan 15, 2014
    Last Verified:
    Jan 1, 2014
    Keywords provided by Taner A Usta, MD, MD, Bagcilar Training and Research Hospital
    clomiphene citrate
    amh
    inhibin b
    Additional relevant MeSH terms:
    Infertility

    Study Results

    No Results Posted as of Jan 15, 2014